Levomecor Inc.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Randomized, Double-Blind, Placebo-Controlled Trial of REL-1017 as Adjunctive Treatment for MDD (NCT06011577) | Levomecor Inc. | 2023-08-17 |
| A Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder (MDD) (NCT04855747) | Levomecor Inc. | 2021-03-30 |
Track Levomecor Inc. automatically
Every clearance here is in the API, with alerts when new ones post.